Sponsor Pipeline

Hudson Biotech Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
8
Recruiting
1
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
6
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07481747 Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are… Obesity Recruiting
Phase 2
NCT07437547 BPC 157 for Acute Hamstring Muscle Strain Repair Hamstring Muscle Strain Recruiting
NCT07437560 Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable… NonSegmental Vitiligo Recruiting
NCT07437586 Topical GHK-Cu Gel for Acute Skin Wound Healing Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) Recruiting
NCT07467447 Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight Obesity Recruiting
NCT07481734 Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) Metabolic Associated Steatotic Liver Disease Recruiting
NCT07505745 MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity Prediabetes Recruiting
Phase 1/2
NCT07487363 TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD Atherosclerotic Cardiovascular Diseases Recruiting
Disease Areas
Get alerts when Hudson Biotech's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free